๐จ Publish Open Access with Zero APCs!
Researchers affiliated with eligible institutions in Hungary can publish Open Access with no APCs under a limited-time publishing trial.
๐จ Submit: https://bit.ly/4cEeIar
@readbentham.bsky.social
@readbentham.bsky.social๐จ Publish Open Access with Zero APCs!
Researchers affiliated with eligible institutions in Hungary can publish Open Access with no APCs under a limited-time publishing trial.
๐จ Submit: https://bit.ly/4cEeIar
@achronicvoice.com"โMaybe itโs my #photography background, but #ophthalmology is very #visual,โ [Song] says. โYou can see the #ImmuneCells floating in the eye, and you make a #diagnosis. I think that just came natural to me.โ": buff.ly/ChE0sYX
via YaleMed
#ResearchSky #MedSky #researachers #research #CrossDiscipline
@readbentham.bsky.social๐งฌ Call for Papers โ Current Bioinformatics
Submit your research on bioinformatics, computational biology, genomics, proteomics, data science, and emerging computational approaches in life sciences.
@readbentham.bsky.socialPublish Open Access | Zero APC
โณ Limited-Time Opportunity for Researchers & Academicians
๐ฅ ๐๐ฎ๐๐ฆ๐ข๐ญ ๐๐จ๐ฎ๐ซ ๐๐จ๐ซ๐ค ๐๐จ: https://bit.ly/4tFVwQ2
๐๏ธ Submit by ๐๐๐๐๐ฆ๐๐๐ซ ๐๐๐ฌ๐ญ ๐๐๐๐ to avail this offer (applicable to general articles).
@readbentham.bsky.socialโณ Complimentary Open Access | Current Physics
Publish your research with zero APCs in Current Physics until December 31, 2026.
๐จ Submit: https://bit.ly/4AfAf49
@digitalcivics.bsky.socialSome really interesting research made available here courtesy of The Wolfson Digital Archaeology & Heritage Lab (check them out at @dah-lab.bsky.social )
@readbentham.bsky.social๐งช Indole-3-Carboxaldehyde & Drug Discovery
Indole-3-carboxaldehyde (I3A) is a promising scaffold for developing bioactive compounds with anticancer, anti-inflammatory, antibacterial, and other therapeutic activities.
Read here: https://bit.ly/4dEv4AW
@readbentham.bsky.social๐งช Current Topics in Medicinal Chemistry
Submit your research on the latest advances in medicinal chemistry, drug discovery, pharmacology, and pharmaceutical sciences.
๐จSubmit here: https://bit.ly/462LAXa
@readbentham.bsky.socialโณ Zero APC | Gene Editing Technologies
Submit your research to this peer-reviewed journal and publish Open Access with zero APCs until December 31, 2026.
๐ Submit here: https://bit.ly/4qQX49W
@readbentham.bsky.social๐จ Publish Open Access free of APCs!
Researchers from leading Czech institutions can submit papers under a limited-time Bentham Science trial with zero APCs.
Submit now: https://bit.ly/42ecWYP
#OpenAccessSky #ZeroAPCSky #PublishSky #ResearchSky #AcademicSky #SciSky
@readbentham.bsky.social๐ฏ Current Cancer Drug Targets
A Scopus-indexed Bentham Science journal covering emerging cancer drug targets, molecular mechanisms, drug discovery, and innovative therapies.
๐ฉ Submit: https://bit.ly/46jNGCl
@noeldickover.bsky.socialThe Brain Drain of scholars and researchers moving away from the United States is under way. And those remaining in the US will be dumber and poorer as a result.
#AcademicSky #ResearchSky
@readbentham.bsky.social๐งฌ Chlorogenic Acid & Pancreatic Cancer
Chlorogenic acid suppressed pancreatic cancer cell growth, migration, and invasion while promoting apoptosis through the AKT/GSK-3ฮฒ/ฮฒ-catenin pathway.
๐ Read here: https://bit.ly/4xgCnWz
@cmu.eduAs #football season officially kicks off, CMU student-athletes are helping propel research forward on the future of safety for the sport. ๐
Members of the Tartan Football team are essential players in a groundbreaking study led by neuroscientist Brad Mahon.
@readbentham.bsky.social๐จ Publish Open Access free of APCs!
Calling researchers from participating Bulgarian universities & research institutions. Publish with zero APCs under Bentham's OA trial.
๐ Submit by 31 Oct 2026.
Submit now: https://bit.ly/3Qwdu9P
#ResearchSky #AcademicSky #SciSky #OpenAccessSky #PublishSky
@readbentham.bsky.social๐งช EFMC International Medicinal Chemistry Symposium 2026
Bentham Science is delighted to attend #EFMC2026 in Basel, Switzerland! Visit us at Booth 48 to connect with researchers, authors, and industry professionals.
๐ Basel, Switzerland | Booth 48
@readbentham.bsky.social๐ Current Pharmaceutical Biotechnology | IF 2.9
A high-impact Bentham Science journal publishing research and reviews in biopharmaceuticals, molecular biotechnology, drug development, and applied life sciences.
๐ฉ Submit: https://bit.ly/4zWw7Wm
@readbentham.bsky.socialPublish Open Access | Zero APC
โณ Limited-Time Opportunity for Researchers & Academicians
๐ฅ ๐๐ฎ๐๐ฆ๐ข๐ญ ๐๐จ๐ฎ๐ซ ๐๐จ๐ซ๐ค ๐๐จ: https://bit.ly/4tFVwQ2
๐๏ธ Submit by ๐๐๐๐๐ฆ๐๐๐ซ ๐๐๐ฌ๐ญ ๐๐๐๐ to avail this offer (applicable to general articles).
@readbentham.bsky.social๐๐๐ฅ๐ฅ ๐๐จ๐ซ ๐๐๐ฉ๐๐ซ๐ฌ | ๐๐ก๐๐ฆ๐๐ญ๐ข๐ ๐๐ฌ๐ฌ๐ฎ๐
Intelligent Systems, Digital Trust, and Resilient Decision-Making in Complex Socio-Technical Environments
๐จ ๐๐ฎ๐๐ฆ๐ข๐ญ ๐๐จ๐ฎ๐ซ ๐๐๐ง๐ฎ๐ฌ๐๐ซ๐ข๐ฉ๐ญ: https://bit.ly/3T5qm7T
@aasjournal.bsky.socialBeyond EPICC, Dr. Chen has also been involved in developing MAX1, a detailed model capturing 940 chemical reactions to improve predictions of ozone and other pollutants.
Explore the research: doi.org/10.1007/s003...
#Researchsky #EdSky